The Emerging Clinical Importance of Non-O157 Shiga Toxin--Producing Escherichia coli

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1The Risk of the Hemolytic–Uremic Syndrome after Antibiotic Treatment of<i>Escherichia coli</i>O157:H7 Infections2000 · 1,096 citations
2. 2Shiga toxin-producing Escherichia coli isolates from cases of human disease show enhanced adherence to intestinal epithelial (Henle 407) cells1997 · 40 citations
3. 3Characterization and Epidemiologic Subtyping of Shiga Toxin–Producing Escherichia coli Strains Isolated from Hemolytic Uremic Syndrome and Diarrhea Cases in Argentina2006 · 152 citations
4. 4Epidemiology of Sporadic Diarrhea Due to Verocytotoxin-Producing Escherichia coli: A Two-Year Prospective Study1988 · 194 citations
5. 5Toxin Genotypes and Plasmid Profiles as Determinants of Systemic Sequelae in Escherichia coli O157:H7 Infections1989 · 433 citations